French reimbursement reform and its impact on the devices industry
This article was originally published in Clinica
Executive Summary
The reform of the French healthcare reimbursement system is still in its infancy. Some key developments and decisions are yet to take place before the medical device industry has a clear picture of exactly how the new system will affect them, Amanda Maxwell reports.